SCHEMBL23713151

SCHEMBL23713151

NC(=O)Nc1ccc(CO)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PEPD P12955 1/20 0.59
ALDH1A1 P00352 3/20 0.57
NPC1 O15118 1/20 0.57
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
GFER P55789 1/20 0.53
KIF11 P52732 5/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
LMNA P02545 1/20 0.52
PRSS1 P07477 2/20 0.51
F2 P00734 1/20 0.51
PLG P00747 1/20 0.51
PLAU P00749 1/20 0.51
PLAT P00750 1/20 0.51
KLKB1 P03952 1/20 0.51
GLA P06280 1/20 0.47
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837826 0.84 PEPD (0.61) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL5062623 0.83 PEPD (0.80) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL8867308 0.83 PEPD (0.55) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL8530522 0.83 PEPD (0.59) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL18843562 0.82 HDAC1 (0.57) NPC1MAPTMEN1KMT2AHDAC1
SCHEMBL1953686 0.81 ALDH1A1 (0.59) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL14051538 0.81 ALDH1A1 (0.61) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL25230264 0.81 NPC1 (0.61) PEPDALDH1A1NPC1GAAMAPT
SCHEMBL29990643 0.80 PRSS1 (0.47) PEPDALDH1A1NPC1GAAMEN1
SCHEMBL1276799 0.80 MEN1 (0.47) NPC1GAAMEN1KMT2APRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114025763-B Adenosine compound, pharmaceutically acceptable salt or stereoisomer thereof and application 中国人民解放军军事科学院军事医学研究院 2023-09-12 CN disclosed
WO-2021154948-A1 PRODRUGS USEFUL IN ADOPTIVE CELL THERAPY MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2021-08-05 WO disclosed